Dr. Mark C. Genovese, associate professor of medicine and associate chief of the Division of Immunology and Rheumatology at Stanford University Medical Center, will deliver the 15th annual Emil T. Hofman Lecture at 10 a.m. Saturday (Sept. 22) in the DeBartolo Hall auditorium at the University of Notre Dame.
TitledCombating Degenerative Rheumatoid Arthritis: Hope of the Future,the lecture is free and open to the public.
A 1988 graduate of Notre Dame, Genovese earned his medical degree from Johns Hopkins University School of Medicine and completed an internship, residency and chief residency in the Department of Medicine at Stanford. He remained at Stanford as a postdoctoral fellow in the Division of Immunology and Rheumatology and subsequently joined the faculty in the same division.
Genovese has established a clinical research program that focuses on bench-to-bedside transitional medicine in autoimmune diseases. He has participated in a number of investigator-driven studies and in many multi-center trials.
In addition, he collaborates with several other investigators on studies of biomarkers, chemokines, cytokines, and cell surface markers associated with disease progression and response to therapy.
Since joining the faculty at Stanford, Genovese has served as an editor for the textbookPrimary Care Rheumatologyand as an associate editor forKelleys Essentials of Internal Medicine.He also is an editor of the seventh edition ofKelleys Textbook of Rheumatology.
He is an ad hoc reviewer for numerous medical journals, a board member of the Stanford Clinical Research Center, and was the recipient of a Stanford Center of Immunology Clinical ScholarsAward.
The Emil T. Hofman Lecture Series is a medical education program sponsored by St. Joseph Regional Medical Center in conjunction with the Notre Dame Alumni Association. The series honors the dean emeritus of the First Year of Studies and professor emeritus of chemistry at Notre Dame. It is estimated that Hofman taught more than 32,000 Notre Dame students, including thousands who are now physicians, engineers and scientists.